Primary Record
Pleuromutilin
- In stock
- 4,267 g
- Purity
- 99.0 %
- CAS
- 125-65-5
Compound Identifiers & Properties
- CAS
- 125-65-5
- PubChem CID
- 9886081
- SMILES
- C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CO)C
- Canonical SMILES
- C=C[C@]1(C)C[C@@H](OC(=O)CO)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
Names & Synonyms
- Pleuromutilin
- Drosophilin B
- PLEUROMULIN
- Pleuromulina
- Pleuromuline
- Pleuromulinum
- Mutilin 14-glycolate
- Drosopholin B
- (+)-pleuromutilin
- Pleuromulin [INN]
- Antibiotic A 40104C
- Antibiotic BC 757
- 125-65-5
- Pleuromuline [INN-French]
- Pleuromulinum [INN-Latin]
- Pleuromulina [INN-Spanish]
- Pleuromutilin, >=95%
- RefChem:174883
- 3DE4A80MZ1
- UNII-3DE4A80MZ1
- DTXSID9048720
- PLEUROMUTILIN [MI]
- Valnemulin impurity E CRS
- BC-757
- DTXCID501079582
- orb1307865
- CHEMBL3989485
- NSC-121145
- SCHEMBL16947239
- 14-Deoxy-14-((hydroxyacetyl)oxy)mutilin
- EINECS 204-747-5
- GTPL12935
- Glycolic acid, 8-ester with mutilin
- BC 757
- MFCD28154633
- GLXC-19169
- NSC 121145
- A 4014C
- C22H34O5
- Drosophilin B;Mutilin 14-glycolate
- ZINC4214166
- PLEUROMUTILIN [USP IMPURITY]
- Tox21_113131
- BBF-01770
- MSK000173
- Pleuromulin; Tiamulin EP Impurity G
- Tiamulin EP Impurity G (Free Base)
- AKOS032946430
- C22-H34-O5
- CID9886081
- EBC-616447
- NCGC00182969-01
- CAS-125-65-5
- SY348463
- 14-Deoxy-14-[(hydroxyacetyl)oxy]mutilin
- EC 204-747-5
- FT-0650914
- J2.543.806J
- A1200209
- VALNEMULIN HYDROCHLORIDE IMPURITY E [EP IMPURITY]
- [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-hydroxyacetate
- Acetic acid, hydroxy-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, (3aS-(3aalpha,4beta,5alpha,6alpha,8beta,9alpha,9abeta,10S*))-
- Glycolic acid 8-ester with octahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-6-vinyl-3a,9-propano-3aH-cyclopentacycloocten-1(4H)-one
- (3aR,4R,5R,7S,8S,9R,9aS,12R)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-hydroxyacetate
- ((1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo(5.4.3.01,8)tetradecanyl) 2-hydroxyacetate
- (1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0,1,8]tetradecan-6-yl 2-hydroxyacetate
- (1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.01,8]tetradecan-6-yl 2-hydroxyacetate
- (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl Hydroxyacetate (Pleuromutilin)
- (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propanocyclopenta[8]annulen-8-yl hydroxyacetate
- (3aS,4R,5S,6S,8R,9R,9aR,10R)6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate
- (3aS,4R,5S,6S,8R,9R,9aR,12R)-5-Hydroxy-4,6,9,12-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-hydroxyacetate
- (3aS,9abeta,10R)-4beta,6,9,10-Tetramethyl-5alpha-hydroxy-8beta-(2-hydroxyacetyloxy)-6alpha-ethenyl-3aalpha,9alpha-propanodecahydro-1H-cyclopentacyclooctene-1-one
- 204-747-5
- ACETIC ACID, 2-HYDROXY-, (3AS,4R,5S,6S,8R,9R,9AR,10R)-6-ETHENYLDECAHYDRO-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-3A,9-PROPANO-3AH-CYCLOPENTACYCLOOCTEN-8-YL ESTER
- ACETIC ACID, HYDROXY-, (3AS,4R,5S,6S,8R,9R,9AR,10R)-6-ETHENYLDECAHYDRO-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-3A,9-PROPANO-3AH-CYCLOPENTACYCLOOCTEN-8-YL ESTER
- ACETIC ACID, HYDROXY-, 6-ETHENYLDECAHYDRO-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-3A,9-PROPANO-3AH-CYCLOPENTACYCLOOCTEN-8-YL ESTER, (3AS-(3A.ALPHA.,4.BETA.,5.ALPHA.,6.ALPHA.,8.BETA.,9.ALPHA.,9A.BETA.,10S*))-
- Acetic acid, hydroxy-,(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-ylester
- Glycolic acid (3aS,9abeta)-1-oxo-3aalpha,9alpha-[(R)-butane-1,3-diyl]-4beta,6beta,9-trimethyl-5alpha-hydroxy-6-vinyldecahydro-3aH-cyclopentacyclooctene-8beta-yl ester
- Glycolic acid, 8-ester with octahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-6-vinyl-3a,9-propano-3aH-cyclopentacycloocten-1(4H)-one
- Octahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-6-vinyl-3a,9-propano-3aH-cyclopenta-cycloocten-1(4H)-one 8-glycolate
- Tiamulin Hydrogen Fumarate Imp. G (EP); Tiamulin Imp. G (EP); Pleuromutilin; (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl Hydroxyacetate; Valnemulin Imp. E (EP); Tiamulin Hydrogen Fumarate Imp. G; Retapamulin related; Tiamulin Hydrogen Fumarate Impurity G; Valnemulin Hydrochloride Impurity E; Tiamulin Impurity G; Valnemulin Impurity E